Active Ingredient (Generic Name) | Imatinib mesylate |
---|---|
Indication | It is used in the treatment of blood cancer and gastrointestinal stromal tumor. |
Manufacturer | Intas Pharmaceuticals |
Packaging | 10 Capsules in a Strip |
Strength | 100mg |
Delivery Time | 8 Days |
Product Name: Imanib 100mg Capsule
Brand Name: Imanib
Composition: Imatinib Mesylate (100 mg)
Manufacturer: Intas Pharmaceuticals
Form: Capsule
Packaging Size: 10 Strips
Prescription Status: Prescription Only
Product Type: Finished Product
Usage: Clinical
Description:
Imanib 100mg Capsule contains Imatinib Mesylate, a targeted therapy used in the treatment of certain types of blood cancer, such as chronic myeloid leukemia (CML), and gastrointestinal stromal tumors (GISTs). It belongs to a class of medications known as tyrosine kinase inhibitors (TKIs), which work by blocking the abnormal protein that signals cancer cells to multiply. By inhibiting this protein, Imatinib helps slow or stop the growth of cancer cells.
Indications:
Chronic Myeloid Leukemia (CML)
Acute Lymphoblastic Leukemia (ALL) (Philadelphia chromosome-positive)
Gastrointestinal Stromal Tumors (GISTs)
Other rare cancers as directed by oncologists
Key Features:
High-quality oncology product by Intas Pharmaceuticals
Internationally recognized under brand names such as Gleevec/Glivec
Widely used and clinically validated in cancer care
Available in convenient capsule form for oral administration
Product Name: Imanib 100mg Capsule
Brand Name: Imanib
Composition: Imatinib Mesylate (100 mg)
Manufacturer: Intas Pharmaceuticals
Form: Capsule
Packaging Size: 10 Strips
Prescription Status: Prescription Only
Product Type: Finished Product
Usage: Clinical
Description:
Imanib 100mg Capsule contains Imatinib Mesylate, a targeted therapy used in the treatment of certain types of blood cancer, such as chronic myeloid leukemia (CML), and gastrointestinal stromal tumors (GISTs). It belongs to a class of medications known as tyrosine kinase inhibitors (TKIs), which work by blocking the abnormal protein that signals cancer cells to multiply. By inhibiting this protein, Imatinib helps slow or stop the growth of cancer cells.
Indications:
Chronic Myeloid Leukemia (CML)
Acute Lymphoblastic Leukemia (ALL) (Philadelphia chromosome-positive)
Gastrointestinal Stromal Tumors (GISTs)
Other rare cancers as directed by oncologists
Key Features:
High-quality oncology product by Intas Pharmaceuticals
Internationally recognized under brand names such as Gleevec/Glivec
Widely used and clinically validated in cancer care
Available in convenient capsule form for oral administration